Review

Is radical cystectomy the gold standard?

• Binhan Kağan Aktaş
• Ali Memiş

The Risk Stratifications in Non-Muscle Invasive Bladder Cancer: How Much Accurate are the Methods That We Use? A Multi-Directional View

• Barış Kuzgunbay
• Yıldırım Bayazıt

Is intravesical BCG treatment necessary and/or sufficient?

• Sinan Ekici
• Polat Türker

Non-Muscle Invasive Bladder Cancer: Diagnosis and Treatment of Highest-Risk Subgroup

• Yılören Tanıdır
• İlker Tınay

Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer

• Aziz Karaoğlu
• Utku Oflazoğlu
• Necla Demir

Which Treatment Should We Prefer for High-Risk Nonmuscle Invasive Bladder Cancer? Early Cystectomy or Bladder Sparing?

• Ali Furkan Batur
• Sinan Sözen

The Approach to High Risk Bladder Cancers in The Absence of Bacillus Calmette Guérin: What should Be the Treatment and Follow Up?

• Polat Türker
• Levent Türkeri

Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis of Patients with Non-Muscle Invasive Bladder Cancer: A Review Based on Meta-Analysis

• Emre Tüzel

Original Article

Prognostic Values of Inflammatory Markers in Patients with High-grade Lamina Propria-invasive Bladder Cancer

• İsmail Önder Yılmaz
• Mutlu Değer
• Nebil Akdoğan
• İbrahim Atilla Arıdoğan
• Yıldırım Bayazıt
• Volkan İzol

Influence of Primary or Secondary Muscle Invasive Bladder Cancer on Oncologic Outcomes After Radical Cystectomy

• Serdar Çelik
• Anıl Eker
• Ertuğrul Şefik
• İbrahim Halil Bozkurt
• İsmail Basmacı
• Bülent Günlüsoy
• Tansu Değirmenci

Original Articles

Mycobacterium Brumae Extract Fractions with Potential Immunotherapeutic Activity for Bladder Cancer

• Zeliha Ertürk
• Esra Büber
• Haluk Özen
• Ömür Çelikbıçak
• Bekir Salih
• N. Leyla Açan

Medical Oncology

Neoadjuvant chemotherapy in muscle invasive bladder cancer

• Evren Süer
• Kadir Türkölmez

Review

Non-muscle Invasive Bladder Cancer: Identifying Patients to Consider Timely, Initial Cystectomy

• George E. Koch
• Sam S. Chang